| Net Cash Provided by (Used in) Operating Activities |
$369,700 |
USD |
40% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
10,814,843 |
shares |
2.8% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$11,497,600 |
USD |
5.1% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$497,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$458,800 |
USD |
|
Q1 2025 |
Q1 2025 |
| Operating Lease, Liability |
$187,400 |
USD |
262% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$202,000 |
USD |
254% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$261,200 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$78,100 |
USD |
51% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$91,900 |
USD |
157% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$88,700 |
USD |
314% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$14,600 |
USD |
175% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$336,700 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
300,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
300,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$25,674,100 |
USD |
18% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
300,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$1,700 |
USD |
-88% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$23,600 |
USD |
-97% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$24,100 |
USD |
3.9% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |